Detection of Dengue Virus in Plasma of Patients in Nepal

NCT03620487 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 643

Last updated 2023-02-14

No results posted yet for this study

Summary

To test whether Karius Infectious Disease Diagnostic Sequencing assay can detect Dengue Virus in plasma from suspected cases of Dengue or Dengue Fever like-illnesses from samples collected as part of a hospital-based multi-site study conducted in Nepal.

Conditions

  • Dengue Fever

Sponsors & Collaborators

  • Tribhuvan University, Nepal

    collaborator OTHER
  • Karius, Inc.

    lead INDUSTRY

Principal Investigators

  • Krishna Manandhar, PhD · Tribhuvan University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-26
Primary Completion
2020-03-31
Completion
2020-07-31

Countries

  • Nepal

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03620487 on ClinicalTrials.gov